A randomized, double-blind, placebo-controlled, post-marketing phase III study to evaluate the efficacy of GSK Biologicals' influenza vaccine (Fluarix) administered intramuscularly in adults.
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 14 Nov 2006 Status change
- 27 Oct 2006 Status change
- 11 Dec 2005 New trial record.